Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026
-
World Rank (Aug-2026)9,315Market Cap (Aug-2026)0.986 Billion USDWorld Rank (Jan-05-2024)12,817Market Cap (Jan-05-2024)0.484 Billion USDWorld Rank (Jul-30-2023)11,423Market Cap (Jul-30-2023)0.617 Billion USDWorld Rank (Dec-25-2022)12,494Market Cap (Dec-25-2022)0.494 Billion USDWorld Rank (Jan-07-2022)10,875Market Cap (Jan-07-2022)0.77 Billion USDAnnual Revenue in USD10 Million USDAnnual Net Income in USD-114 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website
-
Solid Biosciences
World Rank (Aug-2026)9,317Market Cap (Aug-2026)0.986 Billion USDWorld Rank (Jan-05-2024)20,729Market Cap (Jan-05-2024)0.115 Billion USDWorld Rank (Jul-30-2023)22,447Market Cap (Jul-30-2023)0.086 Billion USDWorld Rank (Dec-25-2022)21,130Market Cap (Dec-25-2022)0.110 Billion USDWorld Rank (Jan-07-2022)19,806Market Cap (Jan-07-2022)0.17 Billion USDAnnual Net Income in USD-174 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileSolid Biosciences is a Life Science company focused on developing transformative treatments to improve the lives of patients living with Duchenne muscular dystrophy (Duchenne). The company estimated annual revenue is currently 12.4 million USD per year. The headquarters is in USA.Company Website -
QuidelOrtho Corporation
World Rank (Aug-2026)9,336Market Cap (Aug-2026)0.981 Billion USDWorld Rank (Jan-05-2024)2,991Market Cap (Jan-05-2024)4.855 Billion USDWorld Rank (Jul-30-2023)2,609Market Cap (Jul-30-2023)5.805 Billion USDWorld Rank (Dec-25-2022)2,474Market Cap (Dec-25-2022)5.594 Billion USDWorld Rank (Jan-07-2022)3,198Market Cap (Jan-07-2022)5.17 Billion USDAnnual Revenue in USD2,730 Million USDAnnual Net Income in USD-1,132 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileQuidel Corporation is a Diagnostic Healthcare Manufacturer Serving company. It core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development and molecular assay development. The company is delivering a continuum of diagnostic solutions from advanced lateral flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare. The headquarters is in USA.
Company Website -
Kura Oncology
World Rank (Aug-2026)9,405Market Cap (Aug-2026)0.966 Billion USDWorld Rank (Jan-05-2024)7,868Market Cap (Jan-05-2024)1.161 Billion USDWorld Rank (Jul-30-2023)10,368Market Cap (Jul-30-2023)0.739 Billion USDWorld Rank (Dec-25-2022)9,716Market Cap (Dec-25-2022)0.781 Billion USDWorld Rank (Jan-07-2022)10,231Market Cap (Jan-07-2022)0.86 Billion USDAnnual Revenue in USD67 Million USDAnnual Net Income in USD-279 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileKura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.Company Website -
Geron Corporation
World Rank (Aug-2026)9,506Market Cap (Aug-2026)0.944 Billion USDWorld Rank (Jan-05-2024)7,962Market Cap (Jan-05-2024)1.135 Billion USDWorld Rank (Jul-30-2023)6,549Market Cap (Jul-30-2023)1.618 Billion USDWorld Rank (Dec-25-2022)9,612Market Cap (Dec-25-2022)0.797 Billion USDWorld Rank (Jan-07-2022)15,170Market Cap (Jan-07-2022)0.38 Billion USDAnnual Net Income in USD-84 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileGeron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.
Facts About CompanyGeron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.
Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.
As on 2022, Geron Corporation has 107 employees.
Company WebsiteWikipedia -
Olema Pharmaceuticals Inc.
World Rank (Aug-2026)9,573Market Cap (Aug-2026)0.930 Billion USDWorld Rank (Jan-05-2024)10,291Market Cap (Jan-05-2024)0.733 Billion USDWorld Rank (Jul-30-2023)15,099Market Cap (Jul-30-2023)0.343 Billion USDWorld Rank (Dec-25-2022)21,255Market Cap (Dec-25-2022)0.107 Billion USDWorld Rank (Jan-07-2022)16,820Market Cap (Jan-07-2022)0.29 Billion USDAnnual Net Income in USD-162 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileOlema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.Company Website -
Design Therapeutics, Inc.
World Rank (Aug-2026)9,579Market Cap (Aug-2026)0.928 Billion USDWorld Rank (Jan-05-2024)19,654Market Cap (Jan-05-2024)0.143 Billion USDWorld Rank (Jul-30-2023)11,986World Rank (Dec-25-2022)11,986Market Cap (Dec-25-2022)0.533 Billion USDWorld Rank (Jan-07-2022)9,455Market Cap (Jan-07-2022)1.00 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-70 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileDesign Therapeutics, INC is a biotechnology company focused on molecules are designed to selectively bind to genetic repeat sequences, modulate gene expression either by restoring or blocking transcription and restore cellular health. The headquarters is in USA. -
Arbutus Biopharma Corporation
World Rank (Aug-2026)9,596Market Cap (Aug-2026)0.924 Billion USDWorld Rank (Jan-05-2024)13,671Market Cap (Jan-05-2024)0.419 Billion USDWorld Rank (Jul-30-2023)14,777Market Cap (Jul-30-2023)0.361 Billion USDWorld Rank (Dec-25-2022)14,340Market Cap (Dec-25-2022)0.374 Billion USDWorld Rank (Jan-07-2022)13,918Market Cap (Jan-07-2022)0.47 Billion USDAnnual Revenue in USD14 Million USDAnnual Net Income in USD-34 Million USDAnnual Results for Period EndingFor year ending December-2025Company WebsiteWikipedia -
Collegium Pharmaceutical
World Rank (Aug-2026)9,617Market Cap (Aug-2026)0.919 Billion USDWorld Rank (Jan-05-2024)8,100Market Cap (Jan-05-2024)1.103 Billion USDWorld Rank (Jul-30-2023)10,025Market Cap (Jul-30-2023)0.785 Billion USDWorld Rank (Dec-25-2022)9,777Market Cap (Dec-25-2022)0.771 Billion USDWorld Rank (Jan-07-2022)11,744Market Cap (Jan-07-2022)0.66 Billion USDAnnual Revenue in USD781 Million USDAnnual Net Income in USD63 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileCollegium Pharmaceutical is a Specialty Pharmaceutical company committed to being the leader in responsible pain management. It has been focused on developing and commercializing new medicines for pain management that reflect its core values and commitment to people suffering from pain, providers and communities. The headquarters is in USA.
Company Website -
Pacira Biosciences
World Rank (Aug-2026)9,625Market Cap (Aug-2026)0.917 Billion USDWorld Rank (Jan-05-2024)6,744Market Cap (Jan-05-2024)1.506 Billion USDWorld Rank (Jul-30-2023)6,485Market Cap (Jul-30-2023)1.645 Billion USDWorld Rank (Dec-25-2022)5,773Market Cap (Dec-25-2022)1.820 Billion USDWorld Rank (Jan-07-2022)5,267Market Cap (Jan-07-2022)2.67 Billion USDAnnual Revenue in USD726 Million USDAnnual Net Income in USD7 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfilePacira BioSciences is a Pharmaceutical company. It is the organization built on high ethical standards an unwavering commitment to patients and transparent communications and have a drive and a desire to improve the world around and make a meaningful difference in the lives of patients, families, communities and society. The headquarters is in USA.Company Website